Ian Livingston is a forecaster/photographer and information lead for the Capital Weather Gang. By day, Ian is a defense and national security researcher at a D.C. think tank. A widespread 4 to 10 ...
Ian Duncan is a reporter covering federal transportation agencies and the politics of transportation. He previously worked at the Baltimore Sun for seven years, covering city hall, the military ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
(RTTNews) - The U.S. Food and Drug Administration has approved AstraZeneca Plc. (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) ENHERTU (fam-trastuzumab deruxtecan-nxki) for the treatment of adult ...
In this context, it is great news that Phase III trials for the University of Oxford/AstraZeneca COVID-19 vaccine will take place in Chile, and an excellent example of the type of collaboration we ...
The Falkland Islands Government informed on Tuesday in a Press Release that it is “pleased” to announce that 3,000 doses of the Oxford-AstraZeneca ... MLA Ian Hansen, said: “This is a ...
BOLTON have sacked manager Ian Evatt. The League One club sit ninth in the table despite expectations of challenging for promotion this season. The Wanderers crashed to another home defeat by ...
AstraZeneca says it plans to participate in the next round of Medicare negotiations under the Inflation Reduction Act. But this time around, the company says … ...
Ian Evatt has been sacked by Bolton after a poor run of results eventually cost him his job - with the decision coming just days after aiming a foul-mouthed dig at his own fans. The 43-year-old ...
IAN Evatt’s reign as manager of Bolton Wanderers has come to an end, The Bolton News understands. The 43-year-old’s departure has yet to be confirmed officially but it is understood there was ...
Reports have emerged this morning that Bolton Wanderers have sacked manager Ian Evatt. The Trotters were defeated 2-1 by Charlton Athletic on Tuesday night, which looks to be the ex-defender's ...
FDA approves AstraZeneca's Datroway, reducing breast cancer progression risk by 37% per TROPION-Breast01 trial results. Datroway's safety profile remains consistent, with 4.2% ILD rate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback